ECMO and Acute MINCT00425685
Use of ECMO in Acute MI
An observational study of ECMO and Acute MI, run by Johann Wolfgang Goethe University Hospital.
Trial summary
ECMO offers an acceptable cardiopulmonary support in adults with similar hospital survival rates as other mechanical support. It is versatile and salvages some patients, who may otherwise die. Read more about this study
- Who is it for?
- Ages 17 to 90 years
- Conditions the study is for
- ECMO and Acute MI
- How many people
- 60 participants
- Where
- No sites listed yet
- Study dates
- Jan 2003to Dec 2006
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 17 to 90 years
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Acute MI
Who cannot join
- Contraindication against ECMO
About this study
Official title: Use of Extracorporeal Membrane Oxygenation in Treatment of Acute Myocardial Infarction Following Cardiac Surgery Procedures
ECMO offers an acceptable cardiopulmonary support in adults with similar hospital survival rates as other mechanical support. It is versatile and salvages some patients, who may otherwise die. Improvement in intermediate term outcome will require multidisciplinary approach to protect organ function and limit organ injury during this support.
Read the detailed description
Extracorporeal membrane oxygenation (ECMO) is an established treatment option in patients with Cardiogenic Schock. We retrospectively reviewed early and mid-term outcome as well as predictors of survival during using ECMO. This report reviews our experience with this support system in last 3 years.
- Conditions
- ECMO and Acute MI
- Keywords
- cardiopulmonary resuscitation, ECMO, shock, survival, heart failure, transplantation, heart assist device.
- Medical subject headings
- Shock, Heart Failure
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Jan 2007 (estimated)
- Study startJan 2003
- Study completionDec 2006
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for ECMO and Acute MIStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Defined population
- Time perspective
- Other
- Enrolment
- 60 participants
Sponsor and investigators
- Lead sponsor
- Johann Wolfgang Goethe University Hospital
- Sponsor type
- University, hospital or other
- Investigators
- Farhad Bakhtiary, MD, Principal investigator, JW Goethe University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00425685
- Sponsor's protocol ID
- Use of ECM in acute MI
- Other IDs
- ECMO and AMI
- Status last verified
- Jan 2007
- First submitted
- 22 Jan 2007
- Last updated
- 23 Jan 2007
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 23 Jan 2007. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Use of Extracorporeal Membrane Oxygenation in Treatment of Acute Myocardial Infarction Following Cardiac Surgery Procedures
- ClinicalTrials.gov ID
- NCT00425685
- Acronym / sponsor ID
- Use of ECM in acute MI
- Conditions
- ECMO and Acute MI
- Keywords
- cardiopulmonary resuscitation, ECMO, shock, survival, heart failure, transplantation, heart assist device.
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 60 participants
- Lead sponsor
- Johann Wolfgang Goethe University HospitalUniversity, hospital or other
- Study start
- Jan 2003
- Study completion
- Dec 2006
- First posted
- 23 Jan 2007 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
ECMO offers an acceptable cardiopulmonary support in adults with similar hospital survival rates as other mechanical support. It is versatile and salvages some patients, who may otherwise die. Improvement in intermediate term outcome will require multidisciplinary approach to protect organ function and limit organ injury during this support.
Detailed description
Extracorporeal membrane oxygenation (ECMO) is an established treatment option in patients with Cardiogenic Schock. We retrospectively reviewed early and mid-term outcome as well as predictors of survival during using ECMO. This report reviews our experience with this support system in last 3 years.
Study design
- Observational model
- Defined population
- Time perspective
- Other
Who may qualify
- Ages
- 17 to 90 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (1 listed)
- Acute MI
Key exclusion criteria (1 listed)
- Contraindication against ECMO
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Not reported in the source record.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Jan 2007.
Related trials for ECMO and Acute MI
RecruitingObservational study
Prognosis of Patients With Mixed Cardiogenic-Vasoplegic Shock
Cardiogenic Shock Acute, Bypass, Cardiopulmonary
Not yet recruitingPhase 4
Ciprofol's Impact on Oxygenator Function in Extracorporeal Membrane Oxygenation (ECMO) Patients
ECMO Treatment, ARDS (Acute Respiratory Distress Syndrome)
Recruiting
Assessment of ECMO in Acute Myocardial Infarction Cardiogenic Shock
Acute Myocardial Infarction, Cardiogenic Shock
RecruitingPhase 4
Revascularization Strategy of Multivessel Disease for Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock Undergoing Veno-arterial Extracorporeal Membrane Oxygenator
Cardiogenic Shock, Acute Myocardial Infarction
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Farhad Bakhtiary, MD principal investigator
JW Goethe University
Questions about this trial
What is this clinical trial studying?
An observational study of ECMO and Acute MI, run by Johann Wolfgang Goethe University Hospital.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 23 Jan 2007. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jan 2007.